Norepinephrine and DDAVP Induced Rise in Tissue Plasminogen Activator

• References

• 1 Grant MB, Guay C, Lottenberg R. Desmopressin stimulates parallel norepinephrine and tissue plasminogen activator release in normal subjects and patients with diabetes mellitus. Thromb Haemostas 1988; 59: 269-272
• 2 Grant PJ, Davies JA, Tate GM, Boothby M, Prentice CRM. Effects of physiological concentrations of vasopressin on haemostatic function in man. Clin Sci 1985; 69: 471-476
• 3 Cash JD, Gader AMA, Da Costa J. The release of plasminogen activator and factor VIII by LVP, AVP, DDAVP, ATIII and OT in man. Br J Haematol 1974; 27: 363-364
• 4 Wiles PG, Grant PJ, Davies JA. The differential effect of arginine vasopressin on skin blood flow in man. Clin Sci 1986; 71: 633-638
• 5 Hariman H, Hughes JR, Grant PJ, Davies JA. (Abstr) The effects of physiological concentrations of vasopressin on components of the fibrinolytic pathway. Thromb Haemostas 1987; 58: 92
• 6 Grant PJ, Wiles PG, Dean HG, Davies JA, Prentice CRM. The physiological effects of vasopressin on haemostasis are not caused by catecholamine release. Thromb Res 1987; 45: 839-843
• 7 Bichet DG, Razi M, Lonergan M, Arthus M-F, Papukna V, Kortas C, Barjon J-N. Haemodynamic and coagulation responses to 1-desamino [8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl J Med 1988; 318: 881-887
• 8 Brink H, Derkx F, Rrommer F, Stibbe J, Knlstee H, Schalekamp M. (Abstr) The fibrinolytic factor VIII: C, von Willebrand factor and haemodynamic responses to DDAVP in patients with nephrogenic diabetes insipidus. Thromb Haemostas 1987; 58: 517